TKL To Open Phase I Clinical Facility

TKL Research, a full-service CRO, is constructing a new clinical research facility in Fair Lawn, NJ, that will include a 30-bed, Phase I unit as well as multiple, outpatient clinical examination rooms. The new facility also provides expanded capabilities for conducting a full range of dermatological safety studies, and joins three other TKL Research clinics in northern NJ as part of the company’s Research Clinics Division. The Fair Lawn facility is expected to be operational early next year.
 
“The Fair Lawn research facility will enable us to meet the increased demand for our services in the diseased-state populations for Phase I trials, in which we have strong patient recruitment expertise,” said TKL Research president and chief executive officer Jon C. Anderson, Ph.D.